Author

H. G. Kim

Observed name: Hyunjeong Kim

Institution: SK bioscience Co., Ltd. (South Korea)

Observed institution: SK bioscience Co., Ltd. (South Korea)

ORCID: 0009-0001-1815-8901

Observed ORCID: 0009-0001-1815-8901

OpenAlex ID: A5075676526

Post-marketing Surveillance of a Live Attenuated Herpes Zoster Vaccine (SKYZoster ® ) in Adults Aged ≥50 Years in Korea

2025 · Sun Heom Baik, Hyeeun Lee, et al. · Infection and Chemotherapy · 7

Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma

2026 · Jii Bum Lee, Sujeong Baek, et al. · Journal for ImmunoTherapy of Cancer · 3

Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer

2026 · Jii Bum Lee, Junwon Yang, et al. · Genome Medicine

Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children

2026 · Hyunjeong Kim, Kihyun Kim, et al. · Infection and Chemotherapy

Works count: 4

Citation count: 10

H-index: 2

I10-index: